LienTeh.net > Ads > Generic (Gilteritinib) GILLIDX

Generic (Gilteritinib) GILLIDX

Inquire / Price

Model Number：

RL10202303151000
Brand Name：

GILLIDX
Origin：

vientiane，LAO PDR
Small Orders：

Small batches also available
Tags：

AML

Details
Description

Packaging Size

84T/bottle
Strength

40mg
Compositon

Gilteritinib
Treatment

Acute myeloid leukemia (AML) with a FMS-like tyrosine kinase 3 (FLT3) mutation
Form

Tablets
Brand

GILLIDX
Quantity Unit

40mg*84T/Bottle
Manufacturer

BIGBEAR Pharma,LAOs PDR

Gilteritinib is a small molecule part of the FLT3 tyrosine kinase inhibitors that presented a greater selectivity and potency when compared with other agents from this group. It is a pyrazinecarboxamide derivative that showed high selectivity to FLT3 preventing the c-Kit -driven myelosuppression observed in other therapies.

Gilteritinib was developed by Astellas Pharma and FDA approved on November 28, 2018. This drug was approved after being designed as an orphan drug with a fast track and priority review status.

Acute Myeloid Leukemia

Indicated for treatment of patients who have relapsed or refractory acute myeloid leukemia (AML) with a FMS-like tyrosine kinase 3 (FLT3) mutation
120 mg PO qDay
Response may be delayed
Continue for at least 6 months for a clinical response or until disease progression or unacceptable toxicity